Mucocutaneous Presentations of Critical and Non-Critical Admitted COVID-19 Patients and Vaccine-Associated Dermatoses: A Study from Iran

The study "Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses" reported on 121 cases of COVID-19 patients over a 14-month period, who presented with various skin conditions. These conditions were categorized into 12 groups: generalized papulopustular eruptions (3 patients), erythroderma (4 patients), maculopapular lesions (16 patients), mucosal lesions (8 patients), urticarial lesions and angioedema (16 patients), vascular injuries (22 patients), vesiculobullous lesions (12 patients), new onset or aggravated dermatoses (9 patients), nail changes (3 patients), hair loss (2 patients), non-specific mucocutaneous problems (16 patients), and vaccine-associated dermatoses (10 patients). The study emphasized the importance of rapid diagnosis of these skin conditions, as they often indicate internal organ damage and could be life-threatening. Extensive mucocutaneous lesions with vascular components or vesiculobullous erosive lesions associated with any cutaneous rash were identified as potential signs of a serious systemic event.